Adults in Ghana generate higher and more durable neutralising antibody titres following primary course COVID-19 vaccination than matched UK adults: The HERITAGE Study.

Kwesi-Maliepaard EM, Alhassan Y, Quaye EK, Kotey VM, Mohammed AM, Agyemang S, Sromani AK, Darko S, Buadii E, Tackie R, Akligoh H, Ibrahim B, Hutchful D, Paemka L, Amoako E, Ngoi JM, Manu A, HERITAGE study team, Greenwood D, Carr EJ, Wu MY, Bauer DLV, Wall EC, Crick Legacy Consortium, Dey D, Quao AR, Ayisi A, Amponsa-Achiano K, Bekoe FA, Awandare G, Quashie PK, Bediako Y

Open source

DOI
10.1186/s12916-025-04157-0
Published
2025 May 28
Container
BMC medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12916-025-04157-0,
  title = {Adults in Ghana generate higher and more durable neutralising antibody titres following primary course COVID-19 vaccination than matched UK adults: The HERITAGE Study.},
  author = {Kwesi-Maliepaard EM and Alhassan Y and Quaye EK and Kotey VM and Mohammed AM and Agyemang S and Sromani AK and Darko S and Buadii E and Tackie R and Akligoh H and Ibrahim B and Hutchful D and Paemka L and Amoako E and Ngoi JM and Manu A and HERITAGE study team and Greenwood D and Carr EJ and Wu MY and Bauer DLV and Wall EC and Crick Legacy Consortium and Dey D and Quao AR and Ayisi A and Amponsa-Achiano K and Bekoe FA and Awandare G and Quashie PK and Bediako Y},
  year = {2025},
  journal = {BMC medicine},
  doi = {10.1186/s12916-025-04157-0},
  url = {https://doi.org/10.1186/s12916-025-04157-0}
}

RIS

TY  - JOUR
TI  - Adults in Ghana generate higher and more durable neutralising antibody titres following primary course COVID-19 vaccination than matched UK adults: The HERITAGE Study.
AU  - Kwesi-Maliepaard EM
AU  - Alhassan Y
AU  - Quaye EK
AU  - Kotey VM
AU  - Mohammed AM
AU  - Agyemang S
AU  - Sromani AK
AU  - Darko S
AU  - Buadii E
AU  - Tackie R
AU  - Akligoh H
AU  - Ibrahim B
AU  - Hutchful D
AU  - Paemka L
AU  - Amoako E
AU  - Ngoi JM
AU  - Manu A
AU  - HERITAGE study team
AU  - Greenwood D
AU  - Carr EJ
AU  - Wu MY
AU  - Bauer DLV
AU  - Wall EC
AU  - Crick Legacy Consortium
AU  - Dey D
AU  - Quao AR
AU  - Ayisi A
AU  - Amponsa-Achiano K
AU  - Bekoe FA
AU  - Awandare G
AU  - Quashie PK
AU  - Bediako Y
PY  - 2025
JO  - BMC medicine
DO  - 10.1186/s12916-025-04157-0
UR  - https://doi.org/10.1186/s12916-025-04157-0
ER  - 

APA

EM, K., Y, A., EK, Q., VM, K., AM, M., S, A., AK, S., S, D., E, B., R, T., H, A., B, I., D, H., L, P., E, A., JM, N., A, M., team, H. S., D, G., EJ, C., MY, W., DLV, B., EC, W., Consortium, C. L., D, D., AR, Q., A, A., K, A., FA, B., G, A., PK, Q., & Y, B. (2025). Adults in Ghana generate higher and more durable neutralising antibody titres following primary course COVID-19 vaccination than matched UK adults: The HERITAGE Study.. BMC medicine. https://doi.org/10.1186/s12916-025-04157-0

Source records